Swartz 2008b.

Trial name or title	NCT‐ 00802100
Methods	Allocation: random. Blindness: single blind. Duration: 28‐ 30 weeks. Design: parallel. Location: multicentre.
Participants	Diagnosis: schizophrenia. Age: 18‐40 years. Gender: male and female participants. History: duration of illness not reported. Setting: not specified.
Interventions	1. Aripiprazole. 2. Olanzapine. 3. Perphenazine.
Outcomes	Long‐time effectiveness, safety and tolerability, use other medication to limit side effects.
Starting date	December 2008.
Contact information	Duke University , U. S. A.
Notes